DEVELOPMENT AND EVALUATION OF FREEZING RESISTANT INTRAVENOUS FLUID

Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2014, Vol 6, Issue 10

Abstract

Objectives: Hemorrhagic or hypovolemic shocks accounts for a large portion of civilian and military trauma deaths due to life-threatening blood loss which requires intravenous fluid infusion to prevent essential deficiencies of fluids. However, at low temperature (-150C) fluid bottles freeze out and can not be used in emergency. In view of that, objective of the present work is to develop a freezing resistant intravenous formulation (FRIV) and its in vivo safety and efficacy evaluation.Methods: FRIV formulations were developed using standardized ringer lactate (RL) formulation protocol, in which varying concentrations of ethanol and glycerol were added to induce desired physiochemical properties. Efficacy of FRIV was evaluated in terms of survival percentage of hemorrhagic animal models (Swiss albino strain mice). Acute toxicity studies were carried out through an infusion at dose levels (0, 20 and 40 ml/Kg b. wt.).Results: In vitro data showed that optimized FRIV (F-10) takes more time (360 ± 21 min) for freezing and less time in thawing (50 ± 4.50 min) in comparison to control which takes (110 ± 15 min) in freezing and (80 ± 7.25 min) in thawing. Formulations were found to be stable and sterile up to six months. In vivo efficacy data showed ≥ 75% survival in animals infused with FRIV as compared to control group in hemorrhagic animal models and no treatment related toxic effects of optimized formulation in terms of hematological, serum biochemistry and histopathological analysis.Conclusion: Pre-clinical safety and efficacy data of the present study indicated that developed FRIV formulation could be used for fluid recovery during the hemorrhagic shocks conditions in the combat scenario. 

Authors and Affiliations

Priyanka Chhabra, Surbhi Saraf, Rashid Ali, Harish Rawat, Gaurav Mittal, Aseem Bhatnagar, Sitanshu Shekhar Lahiri, Amit Kumar

Keywords

Related Articles

ANTIBACTERIAL ACTIVITY OF OIL EXTRACT OF TRIGONA PROPOLIS

Objective: This research is aimed to determine antibacterial activity of some solvents of raw propolis extracts of Trigona sp from Sulawesi, Indonesia and compare it with antibacterial activities of ethanolic and aqueous...

ESTIMATION OF STUNTED, WASTED, WASTED AND STUNTED CHILDREN AT TOWN DHADGAON, DISTRICT-NANDURBAR OF MAHARASHTRA STATE, INDIA

Objective: The aim of present study was to estimate the percentage of all three classes of malnutrition such as i) Stunted ii) wasted iii) wasted and stunted at study site, so that these findings could help to formulate...

EVALUATION OF DIFFERENT CULTURE MEDIA FOR ENHANCED PRODUCTION OF PSEUDOMONAS AERUGINOSA (MTCC NO 2453) BIOMASS AND ITS PROTEINS

Objective: Microorganisms, especially bacteria and its proteins have proven to be potential anti-cancer agents as they selectively attack the tumor cells or tumor micro-environments. The extract of Pseudomonas aeruginosa...

BIOANALYTICAL METHOD DEVELOPMENT OF ATENOLOL IN RAT PLASMA BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY AND TANDEM MASS SPECTROMETRY METHOD: APPLICATION TO PHARMACOKINETIC DRUG-HERB INTERACTION STUDY

Objective: To develop a rapid, simple and sensitive ultra-performance liquid chromatography and tandem mass spectrometry (UPLC-MS/MS) method for quantitative estimation of atenolol (ATN) in rat plasma and its application...

SYNERGISTIC COMBINATIONS OF BROAD SPECTRUM ANTIBIOTICS AGAINST ACINETOBACTER SPP

Objective: The present study was aimed to investigate the resistant pattern of Acinetobacter spp. against 4 broad spectrum antibiotics and the synergistic activity between 3 different combinations of antimicrobials.Metho...

Download PDF file
  • EP ID EP579489
  • DOI -
  • Views 73
  • Downloads 0

How To Cite

Priyanka Chhabra, Surbhi Saraf, Rashid Ali, Harish Rawat, Gaurav Mittal, Aseem Bhatnagar, Sitanshu Shekhar Lahiri, Amit Kumar (2014). DEVELOPMENT AND EVALUATION OF FREEZING RESISTANT INTRAVENOUS FLUID. International Journal of Pharmacy and Pharmaceutical Sciences, 6(10), 490-496. https://www.europub.co.uk/articles/-A-579489